First-in-human study of a thorium-227-labeled mesothelin-targeting antibody-chelator conjugate (MSLN-TTC), in patients with malignant mesothelioma and other solid tumors
作者
A. Minchom,O. Linden,D.G. Knapen,R. Hassan,Lin Fi,K. Jalkanen,V. Subbiah,A. Tafuri,D. FERREIRA,V. Jardine,A. Cleton,J. Pinkert,F. Bladt,H. Hennekes,E. F. Smit
出处
期刊:ESMO open [Elsevier] 日期:2025-11-20卷期号:10 (12): 105905-105905